Your browser doesn't support javascript.
loading
Challenges in initiating and conducting personalized cancer therapy trials: perspectives from WINTHER, a Worldwide Innovative Network (WIN) Consortium trial.
Rodon, J; Soria, J C; Berger, R; Batist, G; Tsimberidou, A; Bresson, C; Lee, J J; Rubin, E; Onn, A; Schilsky, R L; Miller, W H; Eggermont, A M; Mendelsohn, J; Lazar, V; Kurzrock, R.
Afiliación
  • Rodon J; Vall D'Hebron Institute of Oncology and Universitat Autonoma de Barcelona, Barcelona, Spain jrodon@vhio.net.
  • Soria JC; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France.
  • Berger R; Oncology Institute, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Batist G; Segal Cancer Center, Jewish General Hospital Mcgill University, Montreal Quebec Consortium de Recherche en Oncologie Clinique, Quebec, Canada.
  • Tsimberidou A; The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Bresson C; WIN Consortium, Villejuif, France.
  • Lee JJ; The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Rubin E; The National Institute of Biotechnology in the Negev, Ben Gurion University, Beer-Sheva, Israel.
  • Onn A; Oncology Institute, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
  • Schilsky RL; American Society of Clinical Oncology (ASCO), Alexandria.
  • Miller WH; Segal Cancer Center, Jewish General Hospital Mcgill University, Montreal Quebec Consortium de Recherche en Oncologie Clinique, Quebec, Canada.
  • Eggermont AM; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France.
  • Mendelsohn J; The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Lazar V; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France.
  • Kurzrock R; Center for Personalized Cancer Therapy, UC San Diego-Moores Cancer Center, La Jolla, USA.
Ann Oncol ; 26(8): 1791-8, 2015 Aug.
Article en En | MEDLINE | ID: mdl-25908602
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto / Medicina de Precisión / Terapia Molecular Dirigida / Neoplasias / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte / Asia / Europa Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Ensayos Clínicos como Asunto / Medicina de Precisión / Terapia Molecular Dirigida / Neoplasias / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: America do norte / Asia / Europa Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article